SANOFI-AVENTIS RECALLS 30 BATCHES OF LOVENOX

Sanofi-aventis voluntarily recalled 30 batches of syringes containing the anticoagulant Lovenox, due to a problem related to the syringe-filling process, the company announced recently.

The drugmaker said the recalled syringes may contain too much of the active ingredient in Lovenox (enoxaparin). The recalled batches were filled at a single facility and delivered to countries in Europe, Latin America, Asia and Africa. Enoxaparin is sold under the name Clexane in some countries.

Sanofi-aventis said that it discovered the problem through quality control testing and a subsequent investigation.

The firm stressed that enoxaparin is not the subject of the recall.